#2 - A biomaterial-based vaccine

Send a text

In this 2nd episode, our co-hosts discuss the use of a macro-scale material to co-deliver GMCSF and CpG, both APC stimulating agents, as well as AML antigens to kill AML cells.
GUEST: Alex Najibi is now a postdoctoral fellow at Harvard School of Engineering and Applied Sciences, studying bioengineering in David Mooney's lab.
Original study => https://pubmed.ncbi.nlm.nih.gov/31937942/

Support the show

Thanks for listening! Let’s stay in touch:

• Tweet us at @ImmunoTalks
• Share our episodes on LinkedIN and Instagram
• Email us at [e-mail]